Gene transfer of hepatocyte growth factor by electroporation reduces bleomycin-induced lung fibrosis.
Abnormal alveolar wound repair contributes to the development of pulmonary fibrosis after lung injury. Hepatocyte growth factor (HGF) is a potent mitogenic factor for alveolar epithelial cells and may therefore improve alveolar epithelial repair in vitro and in vivo. We hypothesized that HGF could increase alveolar epithelial repair in vitro and improve pulmonary fibrosis in vivo. Alveolar wound repair in vitro was determined using an epithelial wound repair model with HGF-transfected A549 alveolar epithelial cells. Electroporation-mediated, nonviral gene transfer of HGF in vivo was performed 7 days after bleomycin-induced lung injury in the rat. Alveolar epithelial repair in vitro was increased after transfection of wounded epithelial monolayers with a plasmid encoding human HGF, pCikhHGF [human HGF (hHGF) gene expressed from the cytomegalovirus (CMV) immediate-early promoter and enhancer] compared with medium control. Electroporation-mediated in vivo HGF gene transfer using pCikhHGF 7 days after intratracheal bleomycin reduced pulmonary fibrosis as assessed by histology and hydroxyproline determination 14 days after bleomycin compared with controls treated with the same vector not containing the HGF sequence (pCik). Lung epithelial cell proliferation was increased and apoptosis reduced in hHGF-treated lungs compared with controls, suggesting increased alveolar epithelial repair in vivo. In addition, profibrotic transforming growth factor-beta1 (TGF-beta1) was decreased in hHGF-treated lungs, indicating an involvement of TGF-beta1 in hHGF-induced reduction of lung fibrosis. In conclusion, electroporation-mediated gene transfer of hHGF decreases bleomycin-induced pulmonary fibrosis, possibly by increasing alveolar epithelial cell proliferation and reducing apoptosis, resulting in improved alveolar wound repair.
Gazdhar
Amiq
A
Division of Thoracic Surgery, University Hospital, CH-3010 Bern, Switzerland.
Fachinger
Patrick
P
van Leer
Coretta
C
Pierog
Jaroslaw
J
Gugger
Mathias
M
Friis
Robert
R
Schmid
Ralph A
RA
Geiser
Thomas
T
D000818:Animals; D017209:Apoptosis; D001761:Bleomycin / Q000494:pharmacology; D001835:Body Weight; D049109:Cell Proliferation; D018274:Electroporation / Q000379:methods*; D004847:Epithelial Cells / Q000473:pathology; D005786:Gene Expression Regulation; D018014:Gene Transfer Techniques; D017228:Hepatocyte Growth Factor / Q000235:genetics* / Q000378:metabolism*; D006801:Humans; D008297:Male; D011650:Pulmonary Alveoli / Q000473:pathology; D011658:Pulmonary Fibrosis / Q000139:chemically induced / Q000235:genetics* / Q000473:pathology*; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D051381:Rats; D011916:Rats, Inbred F344; D053773:Transforming Growth Factor beta1 / Q000378:metabolism; D014945:Wound Healing
C066855:HGF protein, human; D012333:RNA, Messenger; D053773:Transforming Growth Factor beta1; D001761:Bleomycin; D017228:Hepatocyte Growth Factor